Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Imaging Studies V: Intravenous Urography and Retrograde Pyelography01:22

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study.

Journal of pediatric urology·2022
Same author

Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes.

The Journal of urology·2015
Same author

Limiting radiation exposure during percutaneous nephrolithotomy.

Journal of endourology·2014
Same author

Radiation exposure to a pregnant urological surgeon – what is safe?

BJU international·2014
Same author

Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis/chronic pelvic pain syndrome.

Urology·2012
Same author

Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL).

BJU international·2012

Related Experiment Video

Updated: Jul 9, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

Totally tubeless percutaneous nephrolithotomy.

Tim J Crook1, C R Lockyer, Stephen R Keoghane

  • 1The Solent Department of Urology, St Mary's Hospital, Portsmouth, United Kingdom. timj@crook69.wanadoo.co.uk

Journal of Endourology
|December 22, 2007
PubMed
Summary

Totally tubeless percutaneous nephrolithotomy (PCNL) is a safe and effective treatment for select patients with upper tract stones. This approach avoids nephrostomy tubes and stents, simplifying recovery and potentially reducing complications associated with these devices.

More Related Videos

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

Transmesenteric Laparoscopic Pyeloplasty in Trendelenburg Position for Horseshoe Kidney with Hydronephrosis
03:57

Transmesenteric Laparoscopic Pyeloplasty in Trendelenburg Position for Horseshoe Kidney with Hydronephrosis

Published on: July 8, 2025

Related Experiment Videos

Last Updated: Jul 9, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

Transmesenteric Laparoscopic Pyeloplasty in Trendelenburg Position for Horseshoe Kidney with Hydronephrosis
03:57

Transmesenteric Laparoscopic Pyeloplasty in Trendelenburg Position for Horseshoe Kidney with Hydronephrosis

Published on: July 8, 2025

Area of Science:

  • Urology
  • Minimally Invasive Surgery

Background:

  • Percutaneous nephrolithotomy (PCNL) is a standard treatment for upper tract stones.
  • Traditionally, PCNL involves placing a nephrostomy tube for drainage.

Purpose of the Study:

  • To evaluate the safety and efficacy of totally tubeless percutaneous nephrolithotomy (PCNL).
  • To determine if omitting nephrostomy tubes and ureteral stents is feasible in select PCNL cases.

Main Methods:

  • Retrospective analysis of 100 totally tubeless PCNL procedures performed between 1996 and 2006.
  • Inclusion criteria: uncomplicated cases with minimal bleeding, complete stone clearance, intact pelvicaliceal system, and no residual ureteral stones.

Main Results:

  • Mean stone size was 15.9 mm; mean residual stone burden was 1.74 mm.
  • Low complication rates: 1% transfusion, 1% major sepsis, 1% readmission.
  • High stone clearance rate of 90% at 3 months, with a mean hospital stay of 2.9 days.

Conclusions:

  • Totally tubeless PCNL is a safe and well-tolerated procedure in carefully selected patients.
  • Omitting nephrostomy tubes and stents can be considered a standard of care for these patients.
  • Nephrostomy tubes or stents should be reserved for specific indications requiring them.